What is Capecitabine?

Category: Prescription Drugs

Most popular types: Xeloda

false

Capecitabine is an anteneoplastic agent used for the treatment of metastatic colorectal cancer, an adjuvant therapy of Dukes' C colon cancer and treatment of metastatic breast cancer

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Breast cancer 3 1
Colon cancer 3 6
Rectal cancer 2 1
Neuroendocrine tumor 1 3
Pancreatic neuroendocrine tumor 1 0

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
1
Moderate
5
Mild
4
None
5

Commonly reported side effects and conditions associated with Capecitabine

Side effect Patients
Hand-foot syndrome 3
Diarrhea 2
Nausea 2
Acid reflux 1
Dizziness with nausea 1
Fatigue 1

Show all 12 reported side effects

Dosages

Based on patients currently taking Capecitabine

Dosage Patients
1,500 mg twice daily 2
3,000 mg every other week 1
2,500 mg daily 1

Why patients stopped taking Capecitabine

Multiple reasons could be selected

Reason Patients
Course of treatment ended 3
Did not seem to work 3
Side effects too severe 2
Doctor's advice 1
See all 7 patients who've stopped taking Capecitabine

Duration

Currently taking Capecitabine

Duration Patients
6 months - 1 year 2
1 - 2 years 1
2 - 5 years 1

Stopped taking Capecitabine

Duration Patients
Less than 1 month 1
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 14
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 1
Somewhat hard to take 2
A little hard to take 5
Not at all hard to take 7
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 3
< $25 1
Not specified 10

What people switch to and from

Patients started taking Capecitabine after stopping:

Treatment Patients
Anastrozole (Arimidex) 1
Everolimus (Afinitor) 1
Letrozole (Femara) 1

Patients stopped taking Capecitabine and switched to:

Treatment Patients
Everolimus (Afinitor) 1
Last updated:

2 patient evaluations for Capecitabine

Oct 18, 2011 (Started Apr 13, 2011)

  • Effectiveness
    Slight (for breast cancer)
  • Side effects
    Moderate (nausea, memory problems, acid reflux, diarrhea, fatigue, hand-foot syndrome)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 4000 mg Daily
Side effects: nausea, memory problems, fatigue, diarrhea, acid reflux

  • 0 helpful marks

Dec 31, 2010 (Started Nov 15, 2010)

  • Effectiveness
    Can't tell (for colon cancer)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1000 mg Daily
Cost: $50-99 monthly

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Capecitabine